NovaBay Pharmaceuticals (NBY) 2013年年度报告「NYSE」.pdf

《NovaBay Pharmaceuticals (NBY) 2013年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《NovaBay Pharmaceuticals (NBY) 2013年年度报告「NYSE」.pdf（99页珍藏版）》请在三个皮匠报告上搜索。

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K(Mark One)X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2013 OR?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT O

2、F 1934 For the transition period from to Commission file number 001-33678 NOVABAY PHARMACEUTICALS,INC.(Exact name of registrant as specified in its charter)Delaware 68-0454536(State or other jurisdiction of incorporation ororganization)(I.R.S.Employer Identification No.)5980 Horton Street,Suite 550,

3、Emeryville CA 94608(Address of principal executive offices)(Zip Code)Registrants Telephone Number,Including Area Code:(510)899-8800 Securities registered pursuant to Section 12(b)of the Act:Title of each class Name of each exchange on which registeredCommon Stock,$0.01 par value per share NYSE Mkt S

4、ecurities registered pursuant to Section 12(g)of the Act:None Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No X Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d

5、)of the Act.Yes No X Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12months(or for such shorter period that the registrant was required to file such reports),and(2)has been

6、subject to such filing requirements for the past 90 days.Yes X No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every Interactive Data File required to be submittedand posted pursuant to Rule 405 of Regulation S-T during the pr